SLC6A3 and attention deficit-hyperactivity disorder: The importance of DAT activity in DA circuitry is supported by the effects of many drugs of abuse and neurotoxins; current pharmacological therapeutic strategies for diseases like ADHD or a major depression involve drugs such as psychostimulants or triple reuptake inhibitors (6–8).